Advertisement
Screener

Elanco Animal Health Incorporated (ELAN) Expense Breakdown

Elanco Animal Health Incorporated Expense Breakdown

No Expense Breakdown for ELAN on this site yet.

  • 2026-06-30: Reportable $570.00M.
  • 2025-06-30: Reportable $528.00M.

Source checked: the stored Expense Breakdown page for ELAN.

Expenses by product

Cost of sales: each quarter (3 month)

Quarter endReportable
2026-06-30$570.00M
2025-06-30$528.00M

Costs and Expenses: each quarter (3 month)

Quarter endReportable
2026-06-30$596.00M
2025-06-30$565.00M

General And Administrative Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$139.00M
2025-06-30$128.00M

Income Tax Expense (Benefit): each quarter (3 month)

Quarter endReportable
2026-06-30$2.00M
2025-06-30$14.00M

Research and development: each quarter (3 month)

Quarter endReportable
2026-06-30$92.00M
2025-06-30$92.00M

Selling And Marketing Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$310.00M
2025-06-30$272.00M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05